Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ENDO PHARMS

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 32
  • 0 comments

FDA approve OXYMORPHONE HYDROCHLORIDE

Comment Full text

PURDUE PHARMA LP

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 37
  • 0 comments

FDA approve BUPRENORPHINE

Comment Full text

SPECGX LLC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 33
  • 0 comments

FDA approve OXYCODONE HYDROCHLORIDE

Comment Full text

CEPHALON

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 37
  • 0 comments

FDA approve FENTANYL CITRATE

Comment Full text

SPECGX LLC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 33
  • 0 comments

FDA approve MORPHINE SULFATE

Comment Full text

MYLAN INSTITUTIONAL

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 26
  • 0 comments

FDA approve REMIFENTANIL HYDROCHLORIDE

Comment Full text

ACTAVIS LABS UT INC

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 32
  • 0 comments

FDA approve ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Comment Full text

B BRAUN

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 34
  • 0 comments

FDA approve HEPARIN SODIUM

Comment Full text

RHODES PHARMS

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 33
  • 0 comments

FDA approve HYDROMORPHONE HYDROCHLORIDE

Comment Full text

PURDUE PHARMA LP

  • FDA Approval
  • Dec. 18, 2023, 09:48 UTC
  • 30
  • 0 comments

FDA approve MORPHINE SULFATE

Comment Full text
  • Previous
  • 612
  • 613
  • 614
  • 615
  • 616
  • Next

Search

News categories

  • Technical Exchange News(11949)
  • Event(4887)
  • SEC News(244935)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(147966)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin